Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07509138

Quality of Life in Women Using LARC Contraception

Quality of Life in Women Using LARC Contraception: Cross-Sectional Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
427 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

assessment of quality of life in women using LARC

Detailed description

The ability to control one's fertility is a cornerstone of reproductive health and personal autonomy, fundamentally influencing women's educational, economic, and social trajectories. Modern contraception provides this control, offering a diverse range of methods that allow women and couples to plan if and when to have children. The choice of contraceptive method is a deeply personal decision, often guided by a complex interplay of medical history, lifestyle, personal values, and an individual's priorities regarding efficacy, convenience, and potential side effects (Bangar \& Bansal, 2023). Long-Acting Reversible Contraception (LARC) emerged as a highly effective and increasingly popular category. LARC methods are distinguished by their requirement for administration by a healthcare provider but offer protection against pregnancy for an extended period, ranging from three to ten years, without any ongoing user action. Their "forget-and-forget" nature eliminates the need for daily, weekly, or monthly adherence, resulting in typical-use effectiveness rates that rival those of permanent sterilization. (Francis et al., 2024). While the clinical effectiveness of LARC in preventing pregnancy is well-established, a comprehensive understanding of its impact must extend beyond this singular outcome to encompass the broader concept of quality of life (QoL). Quality of life is a multidimensional construct that includes physical well-being, psychological state, social relationships, and environmental factors. For a woman using contraception, QoL is affected not only by her confidence in avoiding an unintended pregnancy but also by her experience with method-related side effects (such as changes in bleeding patterns, mood, or weight), the convenience of use, and the overall sense of control over her reproductive health. (Alsammani \& Ahmed, 2023)

Conditions

Interventions

TypeNameDescription
DEVICEEtonogestrel ImplantInsertion of a single etonogestrel-releasing subdermal contraceptive implant in the upper arm by a trained healthcare provider according to standard clinical practice.
DEVICELevonorgestrel Intrauterine DeviceInsertion of a levonorgestrel-releasing intrauterine device into the uterine cavity by a trained healthcare provider for long-acting contraception.
DEVICECopper Intrauterine DeviceInsertion of a copper intrauterine device into the uterine cavity by a trained healthcare provider as a non-hormonal long-acting contraceptive method.

Timeline

Start date
2026-04-01
Primary completion
2028-04-01
Completion
2028-07-01
First posted
2026-04-03
Last updated
2026-04-03

Source: ClinicalTrials.gov record NCT07509138. Inclusion in this directory is not an endorsement.